The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine

The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine

The emergence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) in China, reported to the World Health Organization on December 31, 2019, has led to a large global pandemic and is a major public health issue. As a result, there are more than 200 clinical trials of COVID-19...

Full description

Saved in:
Bibliographic Details
Main Authors: Tyler C. Beck (Author), Kyle R. Beck (Author), Calvin B. Holloway (Author), Richard A. Hemings (Author), Thomas A. Dix (Author), Russell A. Norris (Author)
Format: Book
Published: Frontiers Media S.A., 2020-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items